Psychiatric Research Institute
December 9, 2024
UAMS Researcher Receives $3.3 Million Grant to Study PTSD Therapies in Prisons
LITTLE ROCK — A University of Arkansas for Medical Sciences (UAMS) researcher has been awarded a grant worth $3.3 million from the National Institute on Drug Abuse (NIDA) to study the effectiveness of two therapeutic options in treating post-traumatic stress disorder (PTSD) in prison populations.
December 2, 2024
UAMS to Host Northwest Arkansas Schizophrenia Conference to Examine Complex Issues Surrounding Mental Illness
FAYETTEVILLE — The University of Arkansas for Medical Sciences (UAMS) is hosting a conference, the first of its kind in Northwest Arkansas, dedicated to raising awareness about schizophrenia and the issues that accompany the mental illness.
November 20, 2024
Arkansas Attorney General Provides $600,000 Grant to Support Women’s Mental Health Fellowship
LITTLE ROCK — The University of Arkansas for Medical Sciences has received a $600,000 grant from Arkansas Attorney General Tim Griffin to support a women’s mental health fellowship in an effort to address the impact of the opioid epidemic on women and to help reduce the state’s maternal mortality rate.
November 19, 2024
UAMS Invests Ashley Acheson, Ph.D., in Wilbur D. Mills Distinguished Chair in Alcoholism and Drug Abuse Prevention
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) College of Medicine invested Ashley Acheson, Ph.D., professor and vice chair for research for the UAMS Department of Psychiatry, in the Wilbur D. Mills Distinguished Chair in Alcoholism and Drug Abuse Prevention during a Nov. 12 ceremony. “This chair is especially meaningful to me…
November 13, 2024
UAMS Center for Addiction Services Employs New Technology to Treat Opioid Addiction
LITTLE ROCK — The drug methadone, commonly used to treat opioid addiction by detoxification and maintenance, requires daily visits to an outpatient clinic as well as countless counseling sessions and drug screenings. Recognizing the barrier that daily visits can pose, the University of Arkansas for Medical Sciences (UAMS) Center for Addiction Services and Treatment is rolling out a hybrid care program designed to better meet the needs of its patients and improve their chances of overcoming their dependence on opioids.
October 15, 2024
‘Drugified’ Depictions Everywhere in America, Says Author Sam Quinones
The American public is “assaulted” with addictive images every day, according to award-winning author Sam Quinones, so it should come as no surprise that so many people are drawn to the abundance of illicit drugs available throughout the country.
October 10, 2024
UAMS Neurodiversity Conference Provides Vibrant Platform for Discussion
In a world increasingly focused on inclusivity, the University of Arkansas for Medical Sciences’ “2024 Neurodiversity Conference: Bridging Health Care Gaps into Adulthood” provided a vibrant platform for discussing the importance of neurodiversity in workplaces, schools and communities. Held at the UAMS Schmieding Center for Senior Health and Education in Springdale, the Sept. 27 event…
October 3, 2024
Schizophrenia Conference Offers Education, Optimism
The more than 250 people who attended the Arkansas Schizophrenia Conference, hosted by the University of Arkansas for Medical Sciences’ Psychiatric Research Institute, left the Sept. 27 event with information about the latest treatment approaches and promising findings.
September 5, 2024
‘Dreamland’ Author Sam Quinones to Discuss Impact of Substance Use on America on Oct. 9
LITTLE ROCK — Award-winning author and journalist Sam Quinones will offer an in-depth look at the world of substance use and its disruptive effects on the United States in a presentation hosted by the University of Arkansas for Medical Sciences (UAMS) Psychiatric Research Institute.
July 31, 2024
UAMS’ Addiction Training Program Renewed for Five More Years
LITTLE ROCK — The University of Arkansas for Medical Sciences’ Addiction Research Training Program was recently awarded $2.4 million from the National Institute on Drug Abuse (NIDA) to renew the program for another five years.
Next page